Molecular determinants of positive allosteric modulation of the human metabotropic glutamate receptor 2
Molecular determinants of positive allosteric modulation of the human metabotropic glutamate receptor 2
复制标题
DOI:
10.1111/bph.13065
复制
发表时间:
2015-05-01
影响因子:
7.3
通讯作者:
Tresadern, G.
中科院分区:
文献类型:
--
作者:
Farinha, A.;Lavreysen, H.;Tresadern, G.
Background and PurposeThe activation of the metabotropic glutamate receptor 2 (mGlu(2)) reduces glutamatergic transmission in brain regions where excess excitatory signalling is implicated in disorders such as anxiety and schizophrenia. Positive allosteric modulators (PAMs) can provide a fine-tuned potentiation of these receptors' function and are being investigated as a novel therapeutic approach. An extensive set of mutant human mGlu(2) receptors were used to investigate the molecular determinants that are important for positive allosteric modulation at this receptor.Experimental ApproachSite-directed mutagenesis, binding and functional assays were employed to identify amino acids important for the activity of nine PAMs. The data from the radioligand binding and mutagenesis studies were used with computational docking to predict a binding mode at an mGlu(2) receptor model based on the recent structure of the mGlu(1) receptor.Key ResultsNew amino acids in TM3 (R635, L639, F643), TM5 (L732) and TM6 (W773, F776) were identified for the first time as playing an important role in the activity of mGlu(2) PAMs.Conclusions and ImplicationsThis extensive study furthers our understanding of positive allosteric modulation of the mGlu(2) receptor and can contribute to improved future design of mGlu(2) PAMs.